CN101322781A - Capsule for treating sphagitis - Google Patents
Capsule for treating sphagitis Download PDFInfo
- Publication number
- CN101322781A CN101322781A CNA2008100623793A CN200810062379A CN101322781A CN 101322781 A CN101322781 A CN 101322781A CN A2008100623793 A CNA2008100623793 A CN A2008100623793A CN 200810062379 A CN200810062379 A CN 200810062379A CN 101322781 A CN101322781 A CN 101322781A
- Authority
- CN
- China
- Prior art keywords
- parts
- larynx
- capsule
- grass
- radix
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000002775 capsule Substances 0.000 title claims abstract description 12
- 239000003814 drug Substances 0.000 claims abstract description 17
- 239000002994 raw material Substances 0.000 claims abstract description 8
- 210000000867 larynx Anatomy 0.000 claims description 22
- 241000628997 Flos Species 0.000 claims description 19
- 244000025254 Cannabis sativa Species 0.000 claims description 16
- 241000245240 Lonicera Species 0.000 claims description 5
- 235000014435 Mentha Nutrition 0.000 claims description 5
- 241001072983 Mentha Species 0.000 claims description 5
- 230000000694 effects Effects 0.000 abstract description 30
- 238000002360 preparation method Methods 0.000 abstract description 8
- 231100000331 toxic Toxicity 0.000 abstract description 2
- 230000002588 toxic effect Effects 0.000 abstract description 2
- 241000205585 Aquilegia canadensis Species 0.000 abstract 1
- 241000596154 Belamcanda Species 0.000 abstract 1
- 244000303040 Glycyrrhiza glabra Species 0.000 abstract 1
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 abstract 1
- 235000006679 Mentha X verticillata Nutrition 0.000 abstract 1
- 235000002899 Mentha suaveolens Nutrition 0.000 abstract 1
- 235000001636 Mentha x rotundifolia Nutrition 0.000 abstract 1
- 240000001659 Oldenlandia diffusa Species 0.000 abstract 1
- 244000274050 Platycodon grandiflorum Species 0.000 abstract 1
- 235000006753 Platycodon grandiflorum Nutrition 0.000 abstract 1
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 abstract 1
- 235000011477 liquorice Nutrition 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 241000700605 Viruses Species 0.000 description 9
- 230000000844 anti-bacterial effect Effects 0.000 description 9
- 239000000843 powder Substances 0.000 description 9
- 208000002193 Pain Diseases 0.000 description 8
- 238000009395 breeding Methods 0.000 description 8
- 230000001488 breeding effect Effects 0.000 description 8
- 230000008929 regeneration Effects 0.000 description 8
- 238000011069 regeneration method Methods 0.000 description 8
- 208000024891 symptom Diseases 0.000 description 7
- 238000005303 weighing Methods 0.000 description 7
- 206010011224 Cough Diseases 0.000 description 6
- 206010020565 Hyperaemia Diseases 0.000 description 6
- 206010062717 Increased upper airway secretion Diseases 0.000 description 6
- 238000005516 engineering process Methods 0.000 description 6
- 210000002741 palatine tonsil Anatomy 0.000 description 6
- 208000026435 phlegm Diseases 0.000 description 6
- 238000011084 recovery Methods 0.000 description 6
- 239000003795 chemical substances by application Substances 0.000 description 5
- 229940079593 drug Drugs 0.000 description 5
- 241000712461 unidentified influenza virus Species 0.000 description 5
- 235000014101 wine Nutrition 0.000 description 5
- 241000709661 Enterovirus Species 0.000 description 4
- 241001570521 Lonicera periclymenum Species 0.000 description 4
- 235000002637 Nicotiana tabacum Nutrition 0.000 description 4
- 244000061176 Nicotiana tabacum Species 0.000 description 4
- 241000725643 Respiratory syncytial virus Species 0.000 description 4
- 241000191940 Staphylococcus Species 0.000 description 4
- 241000194017 Streptococcus Species 0.000 description 4
- 241000193998 Streptococcus pneumoniae Species 0.000 description 4
- 201000010099 disease Diseases 0.000 description 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 4
- 241000411851 herbal medicine Species 0.000 description 4
- 210000003026 hypopharynx Anatomy 0.000 description 4
- 238000004519 manufacturing process Methods 0.000 description 4
- 239000011812 mixed powder Substances 0.000 description 4
- 238000002156 mixing Methods 0.000 description 4
- 231100000614 poison Toxicity 0.000 description 4
- 230000005070 ripening Effects 0.000 description 4
- 210000002460 smooth muscle Anatomy 0.000 description 4
- 210000005070 sphincter Anatomy 0.000 description 4
- 230000001954 sterilising effect Effects 0.000 description 4
- 238000004659 sterilization and disinfection Methods 0.000 description 4
- 238000003756 stirring Methods 0.000 description 4
- 229940031000 streptococcus pneumoniae Drugs 0.000 description 4
- 230000008961 swelling Effects 0.000 description 4
- 210000001519 tissue Anatomy 0.000 description 4
- 239000003440 toxic substance Substances 0.000 description 4
- 241000701161 unidentified adenovirus Species 0.000 description 4
- 244000241235 Citrullus lanatus Species 0.000 description 3
- 235000012828 Citrullus lanatus var citroides Nutrition 0.000 description 3
- 208000019505 Deglutition disease Diseases 0.000 description 3
- 241000167880 Hirundinidae Species 0.000 description 3
- 206010036790 Productive cough Diseases 0.000 description 3
- 208000003251 Pruritus Diseases 0.000 description 3
- 206010057190 Respiratory tract infections Diseases 0.000 description 3
- 206010046306 Upper respiratory tract infection Diseases 0.000 description 3
- 238000010521 absorption reaction Methods 0.000 description 3
- 238000004458 analytical method Methods 0.000 description 3
- 230000003110 anti-inflammatory effect Effects 0.000 description 3
- 230000001684 chronic effect Effects 0.000 description 3
- 239000013078 crystal Substances 0.000 description 3
- 238000011156 evaluation Methods 0.000 description 3
- 235000013305 food Nutrition 0.000 description 3
- 229930182470 glycoside Natural products 0.000 description 3
- 150000002338 glycosides Chemical class 0.000 description 3
- 230000035876 healing Effects 0.000 description 3
- 230000000144 pharmacologic effect Effects 0.000 description 3
- 230000021595 spermatogenesis Effects 0.000 description 3
- 208000024794 sputum Diseases 0.000 description 3
- 210000003802 sputum Anatomy 0.000 description 3
- 238000012795 verification Methods 0.000 description 3
- 206010068319 Oropharyngeal pain Diseases 0.000 description 2
- 201000007100 Pharyngitis Diseases 0.000 description 2
- 208000033809 Suppuration Diseases 0.000 description 2
- 238000009825 accumulation Methods 0.000 description 2
- 208000006673 asthma Diseases 0.000 description 2
- 235000009508 confectionery Nutrition 0.000 description 2
- 239000003172 expectorant agent Substances 0.000 description 2
- 230000003419 expectorant effect Effects 0.000 description 2
- 230000002401 inhibitory effect Effects 0.000 description 2
- 231100000957 no side effect Toxicity 0.000 description 2
- 244000052769 pathogen Species 0.000 description 2
- 230000001047 pyretic effect Effects 0.000 description 2
- 210000000952 spleen Anatomy 0.000 description 2
- 231100000419 toxicity Toxicity 0.000 description 2
- 230000001988 toxicity Effects 0.000 description 2
- UUTKICFRNVKFRG-WDSKDSINSA-N (4R)-3-[oxo-[(2S)-5-oxo-2-pyrrolidinyl]methyl]-4-thiazolidinecarboxylic acid Chemical compound OC(=O)[C@@H]1CSCN1C(=O)[C@H]1NC(=O)CC1 UUTKICFRNVKFRG-WDSKDSINSA-N 0.000 description 1
- SRWKSFRBHIWJSD-UHFFFAOYSA-N 6-cyclohexylhexan-1-ol Chemical compound OCCCCCCC1CCCCC1 SRWKSFRBHIWJSD-UHFFFAOYSA-N 0.000 description 1
- 206010000087 Abdominal pain upper Diseases 0.000 description 1
- 206010063409 Acarodermatitis Diseases 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 235000017166 Bambusa arundinacea Nutrition 0.000 description 1
- 235000017491 Bambusa tulda Nutrition 0.000 description 1
- 241000208671 Campanulaceae Species 0.000 description 1
- 241000208828 Caprifoliaceae Species 0.000 description 1
- 206010007247 Carbuncle Diseases 0.000 description 1
- 244000089742 Citrus aurantifolia Species 0.000 description 1
- 235000008733 Citrus aurantifolia Nutrition 0.000 description 1
- 206010051625 Conjunctival hyperaemia Diseases 0.000 description 1
- 206010010774 Constipation Diseases 0.000 description 1
- 206010059866 Drug resistance Diseases 0.000 description 1
- 208000000059 Dyspnea Diseases 0.000 description 1
- 206010013975 Dyspnoeas Diseases 0.000 description 1
- 241001131815 Egretta garzetta Species 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical group OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 1
- 206010019233 Headaches Diseases 0.000 description 1
- SQUHHTBVTRBESD-UHFFFAOYSA-N Hexa-Ac-myo-Inositol Natural products CC(=O)OC1C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C1OC(C)=O SQUHHTBVTRBESD-UHFFFAOYSA-N 0.000 description 1
- 241000589902 Leptospira Species 0.000 description 1
- 206010033557 Palpitations Diseases 0.000 description 1
- 244000082204 Phyllostachys viridis Species 0.000 description 1
- 235000015334 Phyllostachys viridis Nutrition 0.000 description 1
- 241001448530 Rohdea japonica Species 0.000 description 1
- 241000447727 Scabies Species 0.000 description 1
- 206010040943 Skin Ulcer Diseases 0.000 description 1
- 208000005392 Spasm Diseases 0.000 description 1
- 241000191967 Staphylococcus aureus Species 0.000 description 1
- 206010042674 Swelling Diseases 0.000 description 1
- 235000011941 Tilia x europaea Nutrition 0.000 description 1
- 240000001398 Typha domingensis Species 0.000 description 1
- 208000024780 Urticaria Diseases 0.000 description 1
- 206010047700 Vomiting Diseases 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 239000000443 aerosol Substances 0.000 description 1
- 230000000954 anitussive effect Effects 0.000 description 1
- 208000002399 aphthous stomatitis Diseases 0.000 description 1
- 239000011425 bamboo Substances 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 235000019636 bitter flavor Nutrition 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 208000001848 dysentery Diseases 0.000 description 1
- 201000006549 dyspepsia Diseases 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 206010016766 flatulence Diseases 0.000 description 1
- 229930003935 flavonoid Natural products 0.000 description 1
- 150000002215 flavonoids Chemical class 0.000 description 1
- 235000017173 flavonoids Nutrition 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- CDAISMWEOUEBRE-GPIVLXJGSA-N inositol Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](O)[C@@H]1O CDAISMWEOUEBRE-GPIVLXJGSA-N 0.000 description 1
- 229960000367 inositol Drugs 0.000 description 1
- 230000001788 irregular Effects 0.000 description 1
- 230000001665 lethal effect Effects 0.000 description 1
- 239000004571 lime Substances 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 201000003453 lung abscess Diseases 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 239000012567 medical material Substances 0.000 description 1
- 244000000010 microbial pathogen Species 0.000 description 1
- 230000027939 micturition Effects 0.000 description 1
- 230000009965 odorless effect Effects 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 239000001397 quillaja saponaria molina bark Substances 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 238000005057 refrigeration Methods 0.000 description 1
- 229930182490 saponin Natural products 0.000 description 1
- 150000007949 saponins Chemical class 0.000 description 1
- 208000005687 scabies Diseases 0.000 description 1
- CDAISMWEOUEBRE-UHFFFAOYSA-N scyllo-inosotol Natural products OC1C(O)C(O)C(O)C(O)C1O CDAISMWEOUEBRE-UHFFFAOYSA-N 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 208000013220 shortness of breath Diseases 0.000 description 1
- 231100000019 skin ulcer Toxicity 0.000 description 1
- 239000002689 soil Substances 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- 235000018553 tannin Nutrition 0.000 description 1
- 229920001864 tannin Polymers 0.000 description 1
- 239000001648 tannin Substances 0.000 description 1
- 208000004371 toothache Diseases 0.000 description 1
- 230000008359 toxicosis Effects 0.000 description 1
- 210000003437 trachea Anatomy 0.000 description 1
- 210000004881 tumor cell Anatomy 0.000 description 1
- 230000002792 vascular Effects 0.000 description 1
- 230000008673 vomiting Effects 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
- Medicinal Preparation (AREA)
Abstract
The invention discloses a throat capsule, which is a medicament prepared from the following raw materials in parts by weight: 2-5 parts of blackberry lily, 1-4 parts of platycodon grandiflorum, 3-6 parts of hedyotis diffusa, 0.2-0.5 part of liquorice, 2-4 parts of mint and 2-4 parts of honeysuckle. The preparation of the invention has the advantages of good curative effect, quick effect, high cure rate, no relapse, convenient taking and no toxic or side effect; and has the characteristics of sufficient medicine source, convenient preparation, simple and convenient process and low cost.
Description
Technical field
The present invention relates to a kind of capsule, particularly be meant a kind of capsule that is used for the treatment of pharyngolaryngitis.
Background technology
It is the most common that pharyngolaryngitis belongs to each age level crowd, easily send out and be difficult for a kind of good morbidity of radical cure, particularly hobby is had a liking for the male and the part women of all ages and classes of tobacco and wine, it is various in style in this clinical quasi drugs to go on the market at present, along with continually developing of national drug dosage form, containing agent, tablet, spray, powder are complete.But these kinds are cured the symptoms, not the disease mostly, and produce effects is slow, allow the patient again and again be subjected to the ailing torment and the worry of expensive medical expense.Simultaneously, the patient is because of taking medicine in a large number or aerosol produces the adverse consequences that great drug resistance and toxic and side effects etc. are difficult to avoid to self local skin.
Summary of the invention
The object of the present invention is to provide a kind of capsule that is used for the treatment of pharyngolaryngitis, it is good that preparation of the present invention has curative effect, and produce effects is fast, and the cure rate height does not rebound, and do not recur, and taking convenience, has no side effect; And medicine source abundance, easy to prepare, technology is simple and direct, cheaply characteristics.
In order to achieve the above object, technical scheme of the present invention is:
A kind of capsule that is used for the treatment of pharyngolaryngitis, it is the medicament of being made by the following weight proportion raw material:
Rhizoma Belamcandae 2-5 part;
Radix Platycodonis 1-4 part;
Larynx grass 3-6 part;
Radix Glycyrrhizae 0.2-0.5 part;
Herba Menthae 2-4 part;
Flos Lonicerae 2-4 part.
Described larynx health-care capsule, the preferably medicament of making by the following weight proportion raw material:
1 part of Rhizoma Belamcandae;
2 parts of Radix Platycodoniss;
3 parts of larynx grass;
0.5 part in Radix Glycyrrhizae;
3 parts of Herba Menthaes;
2 parts of Flos Loniceraes.
Rhizoma Belamcandae: call flat bamboo, mountain cattail leaf fan, Herba Iridis japonicae.The source is irides Rhizoma Belamcandae rhizome.Wherein phytomorph is a perennial herb.Be born in hillside, meadow, border, limes marginis or cultivation.Main product Hubei, Henan, Jiangsu, Anhui.Character: the rhizome irregular nodular pattern has short branch, long 4~8cm, diameter 1~1.5cm.Surface yellowish-brown or taupe brown, shrinkage has intensive horizontal ring grain, and several big shape plate-like stem traces are arranged above, and reaching both sides below has fibrous root or root trace.Matter is hard, section yellow, the visible endodermis ring in cross section, and most vascular bundle point.Mildly bitter flavor, peppery.Chemical constituent: contain Rhizoma Iridis Tectori glycoside, Rohdea japonica glycoside, fragrant Rhizoma Iridis Tectori glycoside, Quan and take off and admonish that to pull out dish towering.Function cures mainly: heat-clearing and toxic substances removing, expectorant sore-throat relieving.Be used for the pent-up of pyretic toxicity phlegm-fire, laryngopharynx swelling and pain, accumulation and obstruction of sputum, cough and asthma.
Radix Platycodonis is campanulaceae herbaceos perennial root.Most of area, the whole nation all has.Bigger with northeast, North China's output, the East China quality is more excellent.This medical material is cylindrical or slightly be spindle, and the bottom is gradually thin, the branch that has, slightly distortion, long 10~20 centimetres, 1~1.5 centimetre of diameter.There is shorter rhizome on the top, and the stem trace of several first quarter moon part shapes is arranged on it.Surface white or yellowish white, the surperficial yellowish-brown of not removing crust is to taupe brown; Band is arranged at top, and the hole skin sample spot and the root trace of growing crosswise arranged, and matter is crisp, and section is smooth, and a light brown ring is arranged, and skin zone's off-white color has the crack, the woody part yellowish white.Odorless, little sweet back of distinguishing the flavor of is bitter.Function cures mainly: can reflexive increase the trachea secretion, dilution sputum and stronger phlegm-dispelling functions is arranged; And antitussive effect and antiinflammatory action arranged; Be used for the treatment of expectorant, sore-throat relieving, evacuation of pus, cough with copious phlegm, uncomfortable in chest not smooth, laryngopharynx swelling and pain is cried out, lung abscess vomiting pus, the difficulty in urination, constipation.
The larynx grass: aithullium, natural plant height does not wait at 30~100CM because of the soil girth of a garment, single leaf alternate, the blade lanceolar, long 10~20CM, wide 3~6CM, tip is point gradually, cane is imitative wooden, and flower row umbrella shape is born in stem top or axil, take on a red color when fruit is ripe, the root bark meat, rhizome is imitative wooden, is born in the wild grove in hillside.Function cures mainly: heat-clearing and toxic substances removing, the sharp larynx of antiinflammatory is used for the pent-up of pyretic toxicity phlegm-fire, laryngopharynx swelling and pain, accumulation and obstruction of sputum.
Radix Glycyrrhizae is known as the king of Chinese herbal medicine, invigorating the spleen and replenishing QI, heat-clearing and toxic substances removing, expelling phlegm for arresting cough, relieving spasm to stop pain, coordinating the actions of various ingredients in a prescription.Be used for weakness of the spleen and stomach, fatigue and weakness, shortness of breath and palpitation, cough with copious phlegm, epigastric pain, carbuncle sore tumefacting virus, alimentary toxicosis etc.Especially for nourishing the lung to arrest cough: the treatment cough and asthma.
Herba Menthae: dispelling wind, the heat radiation, ward off dirty, the detoxifcation.Be used for the treatment of affection due to external wind and heat, headache, conjunctival congestion, laryngopharynx swelling and pain, dyspepsia flatulence, aphtha, toothache, skin ulcer scabies, urticaria.
Flos Lonicerae has another name called Flos Lonicerae, Flos Lonicerae, Flos Lonicerae, little egret flower, two precious flowers, is the alabastrum of the evergreen prehensile bejuco of Caprifoliaceae perennial half Radix Ophiopogonis and the flower of just opening.The Flos Lonicerae sweet in the mouth is cold in nature, function heat-clearing and toxic substances removing, dispelling wind and heat pathogens.Flos Lonicerae contains cyclohexanhexanol, flavonoid, inositol, Saponin and tannin etc., has broad-spectrum antibacterial action, various pathogens such as staphylococcus aureus, dysentery bacterium all there is stronger inhibitory action, multiple pathogenic microorganisms such as leptospira, influenza virus and pathogenic moulds are also had inhibitory action.In addition, Flos Lonicerae also has tangible antiinflammatory and refrigeration function, and Flos Lonicerae water and steeping in wine liquid have tangible lethal effect to tentative tumor cell.
Production method is: take by weighing an amount of Rhizoma Belamcandae at first respectively, Radix Platycodonis, larynx grass, Radix Glycyrrhizae, Herba Menthae, Flos Lonicerae.Get Rhizoma Belamcandae earlier, Radix Platycodonis, the larynx grass is common dry, pulverizes and is ground into superfine end, and add Radix Glycyrrhizae and Herba Menthae mixed powder gradually, after all mixing stirring, add gradually in the Honeysuckle Flower, above-mentioned whole powder agent components by after the described mixed, are carried out ripening under 110-125 ℃, sterilization treatment 10-30 minute, make and obtain larynx health-care capsule of the present invention in incapsulating behind the powder.
Beneficial effect of the present invention is: the larynx health-care capsule of the present invention's preparation can suppress breeding and the regeneration of most virus of bottleneck throat (as: rhinovirus, adenovirus, influenza virus, respiratory syncytial virus etc.) and antibacterial (as: streptococcus pneumoniae, streptococcus, staphylococcus etc.), make its smooth muscle loosening, sphincters contract, activate this and distinguish Normocellular breeding and regeneration, make by virus or antibacterial invaded tissue and recovered normal function.It is good that preparation of the present invention has curative effect, and produce effects is fast, and the cure rate height does not rebound, and do not recur, and taking convenience, has no side effect; And medicine source abundance, easy to prepare, technology is simple and direct, cheaply characteristics.
The specific embodiment
Embodiment 1
Take by weighing raw material (kilogram) by following proportioning:
2 parts of Rhizoma Belamcandae; 1 part of Radix Platycodonis; 3 parts of larynx grass; 0.2 part in Radix Glycyrrhizae; 2 parts of Herba Menthaes; 2 parts of Flos Loniceraes.
Production method is: take by weighing Rhizoma Belamcandae according to said ratio at first respectively, Radix Platycodonis, larynx grass, Radix Glycyrrhizae, Herba Menthae, Flos Lonicerae.Get Rhizoma Belamcandae earlier, Radix Platycodonis, the larynx grass is common dry, pulverizes and is ground into superfine end, and add Radix Glycyrrhizae and Herba Menthae mixed powder gradually, after all mixing stirring, add gradually in the Honeysuckle Flower, above-mentioned whole powder agent components by after the described mixed, are carried out ripening under 110-125 ℃, sterilization treatment 10-30 minute, incapsulate promptly after making powder.
The present invention has obtained good curative effect through clinical 588 example tests, and obvious effective rate is unexpectedly up to 100%, and relevant clinical trial is specified in down:
Clinical data: treatment upper respiratory tract infection, as 588 person-times of pharyngolaryngitis sufferers, middle-aged male 352 examples wherein, women's 148 examples, teenager 50 examples, old 38 examples, the oldest 65 years old, minimum 10 years old, long number year of the course of disease, short number sky.
Treatment foundation: clinical symptoms: go up sense, antiadoncus, bottleneck throat hyperemia, pain, itch, dysphagia.
Usage and dosage: each 1-2 grain, day clothes 2 times, no human relations are anxious, and chronic pharyngolaryngitis the patient all once take effect.
Points for attention: avoid cold and uncooked food, tobacco and wine, greasy and maror.
Efficacy evaluation:
(1) recovery from illness, tonsil often is become a full member by enlargement, and bottleneck throat is congested to disappear, and swallows normally, and no sense of discomfort, and not rebounding after healing such as does not recur at advantage.
(2) take a turn for the better, tonsil is normal, and bottleneck throat hyperemia obviously alleviates, other transference cures.
(3) curative effect is not good enough, and clinical symptoms has slight improvement.
Efficacy analysis: recovery from illness 575 examples in 588 routine patients, 10 examples that take a turn for the better, 3 examples that curative effect is not good enough, total effective rate reaches 100%, and cure rate reaches 98%.Through the several years clinical verification, special effect, the tying-in that the present invention has according to Chinese herbal medicine is up, the characteristics of ridging spermatogenesis, and by oral, transduodenal absorption reaches the modest purpose of controlling of specimen.
Contrast with similar drug: the present invention and present existing same veriety (as: watermelon crystal, Herba Pileae Scriptae, Yanyan slice, HOUKANG SAN, HOUTONGLING PIAN ... Deng) compare, its unique distinction is:
(1), produce effects is fast, preparation of the present invention needs only once oral, produce effects does not rebound immediately, does not recur.
(2), medicine source abundance, easy to prepare, technology is simple and direct, advantages such as low cost.
Pharmacological action: the present invention shows through clinical test results, this product can suppress the most virus of bottleneck throat (as: rhinovirus, adenovirus, influenza virus, respiratory syncytial virus ... Deng) and antibacterial (as: streptococcus pneumoniae, streptococcus, staphylococcus ... Deng) breeding and regeneration, make its smooth muscle loosening, sphincters contract, activate this and distinguish Normocellular breeding and regeneration, make by virus or antibacterial invaded tissue and recovered normal function.
Embodiment 2
Take by weighing raw material (kilogram) by following proportioning:
1 part of Rhizoma Belamcandae; 2 parts of Radix Platycodoniss; 3 parts of larynx grass; 0.5 part in Radix Glycyrrhizae; 3 parts of Herba Menthaes; 2 parts of Flos Loniceraes.
Production method is: take by weighing Rhizoma Belamcandae according to said ratio at first respectively, Radix Platycodonis, larynx grass, Radix Glycyrrhizae, Herba Menthae, Flos Lonicerae.Get Rhizoma Belamcandae earlier, Radix Platycodonis, the larynx grass is common dry, pulverizes and is ground into superfine end, and add Radix Glycyrrhizae and Herba Menthae mixed powder gradually, after all mixing stirring, add gradually in the Honeysuckle Flower, above-mentioned whole powder agent components by after the described mixed, are carried out ripening under 110-125 ℃, sterilization treatment 10-30 minute, make incapsulate behind the powder in promptly.
The present invention has obtained good curative effect through clinical 588 example tests, and obvious effective rate is unexpectedly up to 100%, and relevant clinical trial is specified in down:
Clinical data: treatment upper respiratory tract infection, as 588 person-times of pharyngolaryngitis sufferers, middle-aged male 352 examples wherein, women's 148 examples, teenager 50 examples, old 38 examples, the oldest 65 years old, minimum 10 years old, long number year of the course of disease, short number sky.
Treatment foundation: clinical symptoms: go up sense, antiadoncus, bottleneck throat hyperemia, pain, itch, dysphagia.
Usage and dosage: each 1-2 grain, day clothes 2 times, no human relations are anxious, and chronic pharyngolaryngitis the patient all once take effect.
Points for attention: avoid cold and uncooked food, tobacco and wine, greasy and maror.
Efficacy evaluation:
(1) recovery from illness, tonsil often is become a full member by enlargement, and bottleneck throat is congested to disappear, and swallows normally, and no sense of discomfort, and not rebounding after healing such as does not recur at advantage.
(2) take a turn for the better, tonsil is normal, and bottleneck throat hyperemia obviously alleviates, other transference cures.
(3) curative effect is not good enough, and clinical symptoms has slight improvement.
Efficacy analysis: recovery from illness 575 examples in 588 routine patients, 10 examples that take a turn for the better, 3 examples that curative effect is not good enough, total effective rate reaches 100%, and cure rate reaches 98%.Through the several years clinical verification, special effect, the tying-in that the present invention has according to Chinese herbal medicine is up, the characteristics of ridging spermatogenesis, and by oral, transduodenal absorption reaches the modest purpose of controlling of specimen.
Contrast with similar drug: the present invention and present existing same veriety (as: watermelon crystal, Herba Pileae Scriptae, Yanyan slice, HOUKANG SAN, HOUTONGLING PIAN ... Deng) compare, its unique distinction is:
(1), produce effects is fast, preparation of the present invention needs only once oral, produce effects does not rebound immediately, does not recur.
(2), medicine source abundance, easy to prepare, technology is simple and direct, advantages such as low cost.
Pharmacological action: the present invention shows through clinical test results, this product can suppress the most virus of bottleneck throat (as: rhinovirus, adenovirus, influenza virus, respiratory syncytial virus ... Deng) and antibacterial (as: streptococcus pneumoniae, streptococcus, staphylococcus ... Deng) breeding and regeneration, make its smooth muscle loosening, sphincters contract, activate this and distinguish Normocellular breeding and regeneration, make by virus or antibacterial invaded tissue and recovered normal function.
Embodiment 3
Take by weighing raw material (kilogram) by following proportioning:
5 parts of Rhizoma Belamcandae; 4 parts of Radix Platycodoniss; 6 parts of larynx grass; 0.3 part in Radix Glycyrrhizae; 4 parts of Herba Menthaes; 3 parts of Flos Loniceraes.
Production method is: take by weighing Rhizoma Belamcandae according to said ratio at first respectively, Radix Platycodonis, larynx grass, Radix Glycyrrhizae, Herba Menthae, Flos Lonicerae.Get Rhizoma Belamcandae earlier, Radix Platycodonis, the larynx grass is common dry, pulverizes and is ground into superfine end, and add Radix Glycyrrhizae and Herba Menthae mixed powder gradually, after all mixing stirring, add gradually in the Honeysuckle Flower, above-mentioned whole powder agent components by after the described mixed, are carried out ripening under 110-125 ℃, sterilization treatment 10-30 minute, make incapsulate behind the powder in promptly.
The present invention has obtained good curative effect through clinical 588 example tests, and obvious effective rate is unexpectedly up to 100%, and relevant clinical trial is specified in down:
Clinical data: treatment upper respiratory tract infection, as 588 person-times of pharyngolaryngitis sufferers, middle-aged male 352 examples wherein, women's 148 examples, teenager 50 examples, old 38 examples, the oldest 65 years old, minimum 10 years old, long number year of the course of disease, short number sky.
Treatment foundation: clinical symptoms: go up sense, antiadoncus, bottleneck throat hyperemia, pain, itch, dysphagia.
Usage and dosage: each 1-2 grain, day clothes 2 times, no human relations are anxious, and chronic pharyngolaryngitis the patient all once take effect.
Points for attention: avoid cold and uncooked food, tobacco and wine, greasy and maror.
Efficacy evaluation:
(1) recovery from illness, tonsil often is become a full member by enlargement, and bottleneck throat is congested to disappear, and swallows normally, and no sense of discomfort, and not rebounding after healing such as does not recur at advantage.
(2) take a turn for the better, tonsil is normal, and bottleneck throat hyperemia obviously alleviates, other transference cures.
(3) curative effect is not good enough, and clinical symptoms has slight improvement.
Efficacy analysis: recovery from illness 575 examples in 588 routine patients, 10 examples that take a turn for the better, 3 examples that curative effect is not good enough, total effective rate reaches 100%, and cure rate reaches 98%.Through the several years clinical verification, special effect, the tying-in that the present invention has according to Chinese herbal medicine is up, the characteristics of ridging spermatogenesis, and by oral, transduodenal absorption reaches the modest purpose of controlling of specimen.
Contrast with similar drug: the present invention and present existing same veriety (as: watermelon crystal, Herba Pileae Scriptae, Yanyan slice, HOUKANG SAN, HOUTONGLING PIAN ... Deng) compare, its unique distinction is:
(1), produce effects is fast, preparation of the present invention needs only once oral, produce effects does not rebound immediately, does not recur.
(2), medicine source abundance, easy to prepare, technology is simple and direct, advantages such as low cost.
Pharmacological action: the present invention shows through clinical test results, this product can suppress the most virus of bottleneck throat (as: rhinovirus, adenovirus, influenza virus, respiratory syncytial virus ... Deng) and antibacterial (as: streptococcus pneumoniae, streptococcus, staphylococcus ... Deng) breeding and regeneration, make its smooth muscle loosening, sphincters contract, activate this and distinguish Normocellular breeding and regeneration, make by virus or antibacterial invaded tissue and recovered normal function.
Claims (2)
1, a kind of larynx health-care capsule is characterized in that it is the medicament of being made by the following weight proportion raw material:
Rhizoma Belamcandae 2-5 part;
Radix Platycodonis 1-4 part;
Larynx grass 3-6 part;
Radix Glycyrrhizae 0.2-0.5 part;
Herba Menthae 2-4 part;
Flos Lonicerae 2-4 part.
2, larynx health-care capsule as claimed in claim 1 is characterized in that it is the medicament of being made by the following weight proportion raw material:
1 part of Rhizoma Belamcandae;
2 parts of Radix Platycodoniss;
3 parts of larynx grass;
0.5 part in Radix Glycyrrhizae;
3 parts of Herba Menthaes;
2 parts of Flos Loniceraes.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNA2008100623793A CN101322781A (en) | 2008-05-14 | 2008-05-14 | Capsule for treating sphagitis |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNA2008100623793A CN101322781A (en) | 2008-05-14 | 2008-05-14 | Capsule for treating sphagitis |
Publications (1)
Publication Number | Publication Date |
---|---|
CN101322781A true CN101322781A (en) | 2008-12-17 |
Family
ID=40186582
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CNA2008100623793A Pending CN101322781A (en) | 2008-05-14 | 2008-05-14 | Capsule for treating sphagitis |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN101322781A (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107898958A (en) * | 2017-12-22 | 2018-04-13 | 谢小坚 | A kind of cushaw stem oral liquid for helping to give up smoking and preparation method thereof |
CN111920882A (en) * | 2020-09-18 | 2020-11-13 | 天津中医药大学 | A pharmaceutical composition for treating respiratory diseases in summer |
-
2008
- 2008-05-14 CN CNA2008100623793A patent/CN101322781A/en active Pending
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107898958A (en) * | 2017-12-22 | 2018-04-13 | 谢小坚 | A kind of cushaw stem oral liquid for helping to give up smoking and preparation method thereof |
CN111920882A (en) * | 2020-09-18 | 2020-11-13 | 天津中医药大学 | A pharmaceutical composition for treating respiratory diseases in summer |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR101101010B1 (en) | Unstrained rice wine and manufacturing method thereby | |
CN1785024A (en) | Bag-tea for treating pharyngitis and beneficial for throat | |
CN111544543A (en) | Composition with functions of clearing lung, relieving tobacco toxicity, dispelling effects of alcohol and benefiting liver | |
CN101628108B (en) | Traditional Chinese medicinal granules for treating wind-cold evil and preparation method thereof | |
CN103285179B (en) | Traditional Chinese medicine preparation for treating acute pharyngitis and preparation method thereof | |
CN106173049A (en) | A kind of Herba Kalimeridis local flavor Herba Ocimi (Herba Ocimi Pilosi) health tea | |
CN103961614B (en) | Chinese medicine composition for treating respiratory disease and its production and use | |
CN102973863B (en) | Chinese herbal medicine composition for relieving a cough of children and preparation method thereof | |
CN104622991A (en) | Traditional Chinese medicine composition for treating child cold and preparation method thereof | |
CN106805235A (en) | A kind of full nutrition formula food suitable for respiratory disease patient | |
CN101322781A (en) | Capsule for treating sphagitis | |
CN104905031A (en) | Pig gastroenteritis preventing and treating feed additive and production method thereof | |
CN103989762B (en) | Chinese medicine composition of internal organs relieving cough and resolving phlegm and preparation method thereof is rushed down in a kind of heat clearing away | |
CN103861041B (en) | A kind of Chinese medicine composition for the treatment of acute and chronic rhinitis and preparation method thereof | |
CN103550739B (en) | Traditional Chinese medicinal composition for treating acute enteritis and preparation method of traditional Chinese medicinal composition | |
CN104800288A (en) | Traditional Chinese medicine for treating acute viral pharyngitis | |
CN104288234A (en) | Traditional Chinese medicine preparation for preventing and curing caprinae respiratory system diseases, and production method thereof | |
KR102223717B1 (en) | The crude drugs composition of decreation or treating chronic obstructive pulmonary disease, phamacopuncture injection of oriental medicinie containing the same and Injection containing the same | |
KR102632013B1 (en) | A composition containing herbs extract, and manufacturing method of the same | |
CN106938026A (en) | A kind of pharmaceutical composition for treating cold cough and promoting blood circulation and preparation method thereof | |
CN107115456A (en) | Yin-nourishing pill for smoothing intestines and preparation method thereof | |
CN106819382A (en) | A kind of pig starter feed and preparation method thereof | |
CN108653422B (en) | Chinese herbal medicine preparation for treating piglet diarrhea and preparation method thereof | |
CN106110171A (en) | A kind of pure and fresh liquid of Chinese-medicine oral cavity | |
CN105412679A (en) | Traditional Chinese medicine preparation for treating lung abscess and preparation method thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C12 | Rejection of a patent application after its publication | ||
RJ01 | Rejection of invention patent application after publication |
Open date: 20081217 |